Austar Lifesciences Limited (HKG:6118)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7350
+0.0050 (0.68%)
Sep 11, 2026, 9:31 AM HKT

Austar Lifesciences Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
17.2733.8116.08-113.4787.46277.3
Depreciation & Amortization
67.3243.2847.4639.6333.8129.62
Other Amortization
5.95.95.645.923.22.35
Loss (Gain) From Sale of Assets
0.470.470.2-4.10.30.72
Asset Writedown & Restructuring Costs
-5.5----1.09
Loss (Gain) From Sale of Investments
-3.67-3.673.8131.89-3.216.24
Loss (Gain) on Equity Investments
-7.33-4.63-0.3-6.73-9.54-209.65
Provision & Write-off of Bad Debts
1.8-----
Other Operating Activities
12.6718.941.8897.0828.6644.69
Change in Accounts Receivable
1.333.5335.7-39.46-299.98-259.11
Change in Inventory
-63.49-52.4910.8785.5532.04-222.69
Change in Accounts Payable
115.4111.71-36.54-74.97103.01124.87
Change in Unearned Revenue
36.8160.5117.44-200.8-83.33145.51
Change in Other Net Operating Assets
2.4514.75-3.44104.668.46-44.39
Operating Cash Flow
181.45132.198.81-62.65-37.93-103.45
Operating Cash Flow Growth
53.47%33.70%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-44.9-23.1-20.49-69.24-117.11-100.57
Sale of Property, Plant & Equipment
0.230.232.070.170.050.17
Cash Acquisitions
--2.82---
Sale (Purchase) of Intangibles
-1.64-0.44-2.59-1.71-19.33-15.31
Investment in Securities
1194.51-21.86164.26
Other Investing Activities
12.179.3613.6311.85.116.47
Investing Cash Flow
-33.15-12.954.43-54.47-153.1465.02

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-389.73303.14442.36246.88109.1
Total Debt Issued
484.83389.73303.14442.36246.88109.1
Long-Term Debt Repaid
--433.62-387.56-271.76-116.39-45.35
Lease Payments
-16.54-11.74-7.52-10.2-18.07-15.35
Total Debt Repaid
-604.32-433.62-387.56-271.76-116.39-45.35
Net Debt Issued (Repaid)
-119.49-43.89-84.43170.6130.4963.75
Other Financing Activities
19.45-14.02-16.9-23.49-5.19-4.4
Financing Cash Flow
-100.04-57.91-101.32147.12125.359.35

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.66-0.661.130.140.95-0.42
Net Cash Flow
47.660.593.0430.14-64.8220.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
136.5410978.31-131.88-155.04-204.02
Free Cash Flow Growth
48.36%39.18%----
Free Cash Flow Margin
8.46%7.12%5.22%-7.48%-7.19%-10.13%
Free Cash Flow Per Share
0.270.210.15-0.26-0.30-0.40
Levered Free Cash Flow
144.17117.5555.82-88.74-182.04-237.32
Unlevered Free Cash Flow
150.45125.0266.45-80.01-176.04-234.56
Free Cash Flow After Leases
12097.2670.79-142.09-173.11-219.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
16.6811.9817.1513.869.364.4
Cash Income Tax Paid
13.57.66.887.415.697.81
Change in Working Capital
92.5138.0124.03-125.07-179.81-255.8